Please remember the rest of the world is up Covid creek.
I think the NZ sales are really important. First, its a country with no COVID getting in the way of the medical system. Second, you need to compare these oncosil sales to the rate of newly diagnosed LAPC in NZ. I think 2 in a quarter would be a high %. Third, there's no state reimbursement for oncosil in NZ (I think) as yet. Fourth, it shows that if clinicians become committed they will actually use it in preference to standard radiotherapy. I suspect the clinicians dealing with LAPC are a closer knit group in NZ which could help referral/uptake.
If that's replicated in other COVID normal markets it augers well.
Please - don;t lets complain about actual sales.
As for Osprey - watch out for the NZ group publishing their own experience first. Early adopters also want the kudos of publications and presentations. And that creates more evidence as well as momentum.
- Forums
- ASX - By Stock
- OSL
- Ann: Appendix 4C - quarterly
Ann: Appendix 4C - quarterly, page-6
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OSL (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.9¢ |
Change
0.001(12.5%) |
Mkt cap ! $30.58M |
Open | High | Low | Value | Volume |
0.8¢ | 0.9¢ | 0.8¢ | $114.3K | 13.41M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 9972750 | 0.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.9¢ | 22973299 | 19 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 9972750 | 0.008 |
16 | 10727834 | 0.007 |
22 | 20849999 | 0.006 |
26 | 21125008 | 0.005 |
28 | 19463528 | 0.004 |
Price($) | Vol. | No. |
---|---|---|
0.009 | 19681799 | 17 |
0.010 | 14454500 | 14 |
0.011 | 2120000 | 2 |
0.012 | 1494243 | 4 |
0.013 | 621517 | 2 |
Last trade - 16.10pm 18/07/2024 (20 minute delay) ? |
Featured News
OSL (ASX) Chart |